20.3.2026
19.3.2026
8
Apr
2026
15
Find more news and events
Suomeksi
In English
Low labour market participation for non-retirement related reasons may be an early indicator of dementia already years before the first evident symptoms occur. Other erly social of dementia were also identified.
The widely used antidepressant fluoxetine does more than boost serotonin levels: it changes how brain cells manage their energy and rebuild their connections.
Polina Abushik, Anni Hartikainen, Soila Lemmetty, Iuliia Pilipenko, Isabell Rumrich, Atte Eskelinen and Henri Hyvönen were appointed to three-year UEF Research Fellow positions.
A new study explored who are most likely to adopt and actively use digital well-being apps in North Savo, finding that app engagement was, ultimately, most active among those with highest life satisfaction.
Diet doesn’t just fuel the body, it sends molecular signals that can slow down or speed up biological ageing. Biological age, a measure of functional health, can diverge sharply from chronological age.
A study conducted by the University of Eastern Finland and Fimea found that the Finnish news media has given GLP-1 agonists used to treat obesity, such as semaglutide, a great deal of attention while many other new medicines have been ignored.
Patient safety incidents and near misses are a reality in patient care. “With people, there’s always the possibility of human error. But we can learn from our mistakes”, says Professor of Nursing Science Marja Härkänen.
A randomised placebo-controlled Finnish study showed that aspirin therapy does not provide significant relief for people suffering from chronic rhinosinusitis with nasal polyps who are hypersensitive to non-steroidal anti-inflammatory drugs (NSAIDs).
A recent study is the first to report that the fatty acid composition of blood and the enzyme activity associated with it predict the development of bone mineral density from childhood to adolescence.
The University of Aveiro has joined the MIRACLE research project to develop more accurate and personalised methods for cardiovascular disease risk assessment, prevention, and treatment.